Skip to main content
Screener/Healthcare/Biotechnology

TBPH — Theravance Biopharma, Inc.

NASDAQ
$16.76+0.02 (+0.12%)
Small CapUnder $20HealthcareFastest Growing
$8.33
$21.03
$16.57
$16.86
EPS (TTM)$2.03
P/E Ratio8.26
Dividend Yield—
Market Cap$847.6M
Volume180K
Prev Close$16.74
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$45.9M$61.0M$1.15153.5%133.0%
Q3 '25$20.0M$3.6M$0.0759.4%18.1%
Q2 '25$26.2M$54.8M$1.0860.0%209.3%
Q1 '25$15.4M-$13.6M$-0.2725.6%-88.2%
Q4 '24$18.8M-$15.5M$-0.31100.0%-82.8%
Q3 '24$16.9M-$12.7M$-0.2645.1%-75.3%
Q2 '24$14.3M-$16.5M$-0.3430.2%-115.9%
Q1 '24$14.5M-$11.7M$-0.2438.2%-80.4%
Get Your Daily Market Recap